Modulation of T-cell function by gliomas
- 1 October 1991
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 12 (10), 370-374
- https://doi.org/10.1016/0167-5699(91)90068-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Expression of Platelet-Derived Growth Factors, Transforming Growth Factors, and the ros Gene in a Variety of Primary Human Brain TumorsNeurosurgery, 1991
- Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.Journal of Clinical Investigation, 1990
- Isolation and partial purification of growth factors with TGF-like activity from human malignant gliomasJournal of Neurosurgery, 1989
- Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2Journal of Neurosurgery, 1989
- The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cellsInternational Journal of Cancer, 1988
- In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancersJournal of Neurosurgery, 1988
- In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytesJournal of Neurosurgery, 1986
- Neural modulation of immune functionJournal of Neuroimmunology, 1985
- Immunobiology of primary intracranial tumorsJournal of Neurosurgery, 1981
- Relationship of lymphocyte invasion and survival of brain tumor patientsAnnals of Neurology, 1978